The FedEx Institute of Technology and Good Shepherd Pharmacy have announced a partnership to build a new blockchain infrastructure. The platform will prevent the waste of cancer medications.
The project called REMEDI (REclaiming MEDicine) will allow retrieving unused medications from cancer patients to make them available to the disadvantaged. A secure and immutable ledger seems to be the best solution for a safe and confidential distribution.
Good Shepherd Pharmacy’s CEO Phil Baker stated:
“In Tennessee alone, over $10 million worth of perfectly good prescription medication gets flushed down the toilet every year. The blockchain is the solution to that problem. The REMEDI project (REclaiming MEDicine) will divert valuable medication into the hands of patients who would not otherwise use it.”
FedEx Institute will host an event with Blockchain 901 that will offer blockchain enthusiasts and experts the opportunity to connect and discuss the challenges of Good Shepherd’s blockchain resource development program.
The FedEx organization operates in tandem with the research infrastructure of the University of Memphis, and they are both trying to develop continuously new ideas and solutions for a better future.
Cody Behles, FedEx’s assistant director said:
“One of the most valuable resources universities can provide to the innovation ecosystem is the space to explore new ideas and opportunities in an unrestrained environment.”
“Memphis is attracting next-wave startups that recognize that setting up shop in traditional renovation markets like San Francisco is not always the best business decision. We are here to cultivate collaboration through aligned partnerships and amplification or opportunity.”